Your browser doesn't support javascript.
loading
CROI 2022: advances in antiviral therapy for HIV, COVID-19, and viral hepatitis.
Gunaratne, Shauna H; Tieu, Hong-Van; Wilkin, Timothy J; Taylor, Barbara S.
Affiliation
  • Gunaratne SH; Columbia University Irving Medical Center, New York, New York, USA.
  • Tieu HV; Columbia University Irving Medical Center and Weill Cornell Medicine, New York, New York, USA.
  • Wilkin TJ; Weill Cornell Medicine, New York, New York, USA.
  • Taylor BS; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Top Antivir Med ; 30(3): 490-521, 2022.
Article in En | MEDLINE | ID: mdl-36347057

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / COVID-19 Drug Treatment / Hepatitis, Viral, Human Type of study: Prognostic_studies Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: Top Antivir Med Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / COVID-19 Drug Treatment / Hepatitis, Viral, Human Type of study: Prognostic_studies Limits: Child / Humans Country/Region as subject: America do norte Language: En Journal: Top Antivir Med Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States